Zacks Investment Research lowered shares of Imperva Inc (NYSE:IMPV) from a strong-buy rating to a hold rating in a research note released on Wednesday.

According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “

Other research analysts also recently issued reports about the stock. BidaskClub raised shares of Imperva from a sell rating to a hold rating in a report on Tuesday, September 12th. Stifel Nicolaus reissued a hold rating and issued a $47.00 price target on shares of Imperva in a report on Friday, July 14th. Susquehanna Bancshares Inc began coverage on shares of Imperva in a report on Wednesday, June 7th. They issued a positive rating and a $60.00 price target for the company. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the company a buy rating in a report on Monday, August 28th. Finally, Stephens reissued an overweight rating and issued a $61.00 price target (up from $53.00) on shares of Imperva in a report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of Buy and an average target price of $52.78.

Shares of Imperva (NYSE:IMPV) traded down 1.03% during midday trading on Wednesday, hitting $43.35. The company had a trading volume of 25,609 shares. Imperva has a 12-month low of $34.40 and a 12-month high of $57.24. The company’s market capitalization is $1.47 billion. The company’s 50-day moving average price is $44.17 and its 200 day moving average price is $45.59.

Imperva (NYSE:IMPV) last released its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The business had revenue of $74.44 million during the quarter, compared to analysts’ expectations of $74.30 million. During the same quarter in the prior year, the firm posted ($0.23) earnings per share. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. Equities research analysts predict that Imperva will post $0.81 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at

In other news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now directly owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.20% of the company’s stock.

Large investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. purchased a new position in Imperva in the 1st quarter worth $102,000. Migdal Insurance & Financial Holdings Ltd. raised its position in Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after purchasing an additional 866 shares during the period. Amalgamated Bank purchased a new position in Imperva in the 2nd quarter worth $206,000. Principal Financial Group Inc. purchased a new position in Imperva in the 2nd quarter worth $223,000. Finally, KCG Holdings Inc. purchased a new position in Imperva in the 1st quarter worth $201,000. Institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Stock Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related stocks with our FREE daily email newsletter.